Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity?
Fernando A. Bozza(D’Or Institute for Research and Education), Hugo C. Castro Faria Neto(Fundação Oswaldo Cruz), Patrı́cia T. Bozza(Fundação Oswaldo Cruz)
Cited by 44
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527